On May 8, 2025, Benchmark analyst Bruce Jackson announced a significant adjustment for Clene (CLNN, Financial), a company listed on NASDAQ. The analyst has maintained the 'Buy' rating for the stock, reaffirming confidence in Clene's potential despite a reduction in the price target.
Previously set at USD 84.00, the price target for Clene (CLNN, Financial) has been lowered to USD 33.00. This adjustment marks a decrease of approximately 60.71%. Despite this reduction, the 'Buy' rating suggests that the analyst sees continued potential for appreciation in Clene's market performance.
Investors and stakeholders are advised to note that while the price target reflects an updated valuation outlook, the maintained 'Buy' rating indicates sustained optimism from the analyst regarding Clene's future prospects.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 7 analysts, the average target price for Clene Inc (CLNN, Financial) is $43.00 with a high estimate of $84.00 and a low estimate of $20.00. The average target implies an upside of 1,516.54% from the current price of $2.66. More detailed estimate data can be found on the Clene Inc (CLNN) Forecast page.
Based on the consensus recommendation from 7 brokerage firms, Clene Inc's (CLNN, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Clene Inc (CLNN, Financial) in one year is $3.40, suggesting a upside of 27.82% from the current price of $2.66. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Clene Inc (CLNN) Summary page.
